Pfizer's covid vaccine appears to be effective against a key mutation in the more infectious variants of the virus discovered in the U.K. and South Africa. Dr. Scott Gottlieb, former FDA commissioner, discusses the findings.
A coronavirus vaccine developed by Pfizer and BioNTech appears to be effective against a key mutation in the more infectious variants of the virus discovered in the U.K.
and South Africa, according to a study conducted by the U.S. pharmaceutical giant. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joined "Squawk Box" on Friday to discuss the findings.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: